澳洲幸运5开奖号码历史查询

Thermo Fisher Q2 Earnings Beat Estimates, Guidance Lifted

Thermo Fisher Scientific Inc.'s headquarters building in Waltham, Massachusetts

Michael Fein / Bloomberg via Getty Images

Key Takeaways

  • Thermo Fisher posted a second-quarter earnings beat Wednesday as year-over-year profits jumped despite nearly flat revenue.
  • The company also lifted its full-year guidance for revenue and adjusted earnings per share (EPS).
  • Despite the earnings beat, Thermo Fisher shares slipped in premarket trading.

Thermo Fisher Scientific (TMO) reported better second-quarter earnings than analysts had expected Wednesday, and also rais♐ed its projections for the full fiscal year.

The medical device manufacturer reported a 14% year-over-year jump in 澳洲幸运5开奖号码历史查询:net income to $1.55 billion, better than the $1.41 billion analysts had expected, according to estimates compiled by Visible Alpha.

The net income increase came despite revenue slipping 1% to $10.54 billion. Still, the result ღnarrowly beat the $10ꦡ.52 billion analysts had projected.

Thermo Fisher Lifts FY Guidance

After issuing warnings about a 澳洲幸运5开奖号码历史查询:potentially lower sales outlook at the start oꩵf the year, Thermo Fisher's solid Q2 results led the comp𝓡any to adjust its internal projections for the full fiscal year.

Thermo Fisher now projects revenue within a range of $42.4 billion to $43.3 billion, a higher floor than the previous range of $42.3 to $43.3 billion. The company also raised its adjusted 澳洲幸运5开奖号码历史查询:earnings per share (EPS) projections to land within $21.29 to $22.07 per share, compare🥃d to previous guidance of $21.14 to $22.02 per share.

Analysts currently project full-year revenue around $42.95 billion, with an adjusted EPS of $21.70, both within Thermo Fisher's updated ranges.

Despite Wednesday's earnings beat, Thermo Fisher shares were 1.7% lower at $543.00 an hour before the opening bell.

Article Sources
Investopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy.
  1. Thermo Fisher Scientific. "."

Compare Accounts
The offers that appear in this table are from partnerships from which Investopedia receives compensation. This compensation may impact how and where listings appear. Investopedia does not include all offers available in the marketplace.

Related Articles